Autres langues Sandu Pharmaceuticals Limited

Actions

SANDUPHQ6

INE751D01014

Produits pharmaceutiques

Temps Différé Bombay S.E. 07:27:46 24/09/2026			Varia. 5j.	Varia. 1 janv.
37,85 ^INR	+2,02%		+2,97%	+1,12%

11/09	Sandu Pharmaceuticals Limited approuve la nomination de Neeti Madan Kapre en tant qu'administratrice indépendante non exécutive	CI
11/09	Sandu Pharmaceuticals Limited approuve la nomination de Balram Viswanathan au poste de directeur général	CI

Autres langues

11/09	Sandu Pharmaceuticals Limited Approves Appointment of Neeti Madan Kapre as Non Executive Independent Director, Effective 11 July 2026
11/09	Sandu Pharmaceuticals Limited Approves Re-Designation of Balram Viswanathan as Managing Director, Effective from 11 July 2026
11/08	Sandu Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
19/06	Sandu Pharmaceuticals Limited Announces Demise of Umesh Sandu, Member of Audit Committee and Stakeholders Relationship Committee
19/06	Sandu Pharmaceuticals Limited Announces the Demise of Umesh Sandu, Managing Director
05/05	Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
05/05	Sandu Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended 31 March 2026
06/02	Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
12/11	Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
30/09/25	Sandu Pharmaceuticals Limited Approves the Continuation of Shri Vijay Kajarakar as Chief Financial Officer
13/08/25	Sandu Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
29/05/25	Sandu Pharmaceuticals Posts INR3.3 Million Profit in Fiscal Q4
28/05/25	Sandu Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2025, on or Before October 25, 2025
28/05/25	Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025
13/02/25	Sandu Pharmaceuticals Limited Announces Resignation of Shubhada Sandu as Non Executive Non Independent Director
13/02/25	Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024
04/02/25	An undisclosed buyer acquired Sandu Phytoceuticals Private Limited from Sandu Pharmaceuticals Limited.
30/09/24	Sandu Pharmaceuticals Limited Appoints Jayshree Bhasker Sandu as Non Executive Non Independent Women Director
12/08/24	Sandu Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2024
12/08/24	Sandu Pharmaceuticals Limited announces Annual dividend, payable on October 25, 2024
05/06/24	Sandu Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
05/06/24	Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
30/03/24	Sandu Pharmaceuticals Limited Appoints Shri Vijay Kajrekar as Chief Financial Officer
30/03/24	Sandu Pharmaceuticals Limited Announces Executive Changes
20/03/24	Sandu Pharmaceuticals Board Mulls CFO Appointment